Hysterectomy or Endometrial AbLation Trial for Heavy menstrual bleeding

Not Applicable

• Conditions: Heavy menstrual bleeding; Urological and Genital Diseases; Heavy periods NOS

• Registration Number: ISRCTN49013893
• Lead Sponsor: niversity of Aberdeen/NHS Grampian (UK)

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31522846 results (added 17/09/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31577219 results (added 03/10/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-01-28
• Last Update Posted: 29 May 2023
• Study Completion: 2024-08-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: Female
• Target Recruitment: 660

Inclusion Criteria

1. Women less than 50 years of age with heavy menstrual bleeding eligible for endometrial ablation
2. Women who are willing to be randomised between laparoscopic supra-cervical hysterectomy and endometrial ablation

Exclusion Criteria

1. Women with plans to conceive, endometrial atypia, uterine cavity size greater than 11 cm, submucosal fibroids distorting the uterine cavity, contradictions for laparoscopic surgery (e.g. midline lower abdominal incision or known intrabdominal / pelvic adhesions) and previous endometrial ablation (EA)
2. Women who are unable to give informed consent or complete trial documentation

Study & Design

• Study Type: Interventional
• Study Design: Not specified